Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Allen_Chao
|
| gptkbp:focusesOn |
biosimilars
biopharmaceuticals |
| gptkbp:foundedYear |
2012
|
| gptkbp:headquartersLocation |
gptkb:Taipei,_Taiwan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tanvex BioPharma
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:stockExchange |
gptkb:Taipei_Exchange
|
| gptkbp:stockSymbol |
6541.TWO
|
| gptkbp:subsidiary |
Tanvex BioPharma USA, Inc.
|
| gptkbp:website |
https://www.tanvex.com/
|
| gptkbp:bfsParent |
gptkb:Allen_Chao
|
| gptkbp:bfsLayer |
8
|